---
title: "Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095  in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting | PLRX Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283230594.md"
description: "Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting | PLRX Stock News"
datetime: "2026-04-18T09:31:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283230594.md)
  - [en](https://longbridge.com/en/news/283230594.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283230594.md)
---

# Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095  in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting | PLRX Stock News

Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting | PLRX Stock News

### Related Stocks

- [PLRX.US](https://longbridge.com/en/quote/PLRX.US.md)

## Related News & Research

- [Pliant Therapeutics, Inc. $PLRX Stock Position Raised by ADAR1 Capital Management LLC](https://longbridge.com/en/news/294166622.md)
- [Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting | PLRX Stock News](https://longbridge.com/en/news/287275540.md)
- [Optimum RE Spain Socimi returns EUR 2.39 million to sole shareholder via capital reduction](https://longbridge.com/en/news/294659649.md)
- [Greenlight Capital Re director Ariel Warszawski files initial beneficial ownership statement](https://longbridge.com/en/news/294521961.md)
- [Complex Inter-Creditor Conflicts: How TPG’s Multi-Level Investments Can Adversely Impact TPG RE Finance Trust](https://longbridge.com/en/news/294330758.md)